METHYL 1-(4-METHOXYBENZYL)-5-OXOPYRROLIDINE-3-CARBOXYLATE, 95.0%, 500mg

BIS((1H-BENZO[D][1,2,3]TRIAZOL-1-YL)METHYL)AMINE, 95.0%, 1g

Lanthanum oxalate hydrate 99.9% 250 g

Agerafenib, 99.63%, 5mg

Filtration unit with cellulose nitrate membrane Pore size 0.2 μm, without grid, 500 ml, 1000 ml, 75 mm, 12 Piece(s)

2,3,4-Trichloropyridine, 95.0%, 250mg

(1R,3S)-3-Aminocyclopentanecarboxylic acid, 95.0%, 5g

2,4,6-Trichlorophenyl Formate, 97.0%, 1g

4-Allyloxybenzaldehyde, 97%, 25g

5-(aminomethyl)-2-adamantanol hydrochloride hydrate, 95.0%, 250mg

3-(Hydroxymethyl)-1-methylpyrrolidin-2-one, 95.0%, 1g

Prulifloxacin, >98.0%(HPLC)(T), 250mg

4-Methoxy-6-methyl-2-(pyrrolidin-3-yloxy)pyrimidine hydrochloride, 1g